THE HANDBOOK OF ANTIMICROBIAL RESISTANCE: A Comprehensive Clinical and Scientific Guide to the Detection, Management, and Prevention of Drug-Resistant Infections

A Comprehensive Clinical and Scientific Guide to the Detection, Management, and Prevention of Drug-Resistant Infections Antimicrobial resistance has emerged as one of the most consequential and rapidly evolving threats to global public health in modern medicine. Each year, drug-resistant infections claim hundreds of thousands of lives, compromise routine medical and surgical procedures, and challenge clinicians with pathogens that increasingly evade the agents designed to defeat them. Navigating this landscape requires more than clinical intuition — it demands the kind of deep, systematically organized knowledge that only a definitive antimicrobial resistance clinical handbook can provide. This is that handbook. At its scientific foundation, this text offers a thorough exploration of the mechanisms by which microorganisms develop and disseminate resistance — from chromosomal mutations and intrinsic resistance to horizontal gene transfer via plasmids, integrons, and transposons. Specific resistance mechanisms for all major antibiotic classes are examined in detail, including beta-lactamases, carbapenemases, efflux pumps, target modification, and enzymatic inactivation. This mechanistic grounding is essential for interpreting diagnostic results, predicting treatment failure, and making informed therapeutic choices in the management of antibiotic resistance detection and prevention. This comprehensive drug-resistant infection management guide addresses: MRSA, carbapenem-resistant organisms, and gram-negative threats — including ESBL producers, carbapenem-resistant Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa — with detection strategies and evidence-based treatment pathways Antifungal and antiviral resistance — covering resistant Candida species, Aspergillus, HIV, hepatitis B and C, and influenza, with salvage therapy options and clinical decision frameworks Drug-resistant mycobacteria — including MDR and XDR tuberculosis — with detailed guidance on diagnosis, treatment sequencing, and infection control implications Antimicrobial stewardship as both a clinical framework and ethical imperative, with actionable guidance on antibiotic selection, dosing optimization, de-escalation, and duration reduction Hospital infection control pharmacology — covering contact precautions, environmental decontamination, outbreak response, and the role of the clinical laboratory in resistance surveillance Diagnostic stewardship — with guidance on culture, susceptibility testing, molecular diagnostics, and rapid point-of-care testing to ensure microbiological results drive clinical decisions This clinical microbiology resistance reference is written for the full community of clinicians and scientists engaged in fighting drug-resistant infections — infectious disease specialists, clinical microbiologists, hospital pharmacists, intensivists, infection control practitioners, and front-line hospital physicians who encounter resistant pathogens daily. It is equally valuable as a teaching resource for trainees in infectious disease, microbiology, and clinical pharmacy. Secure your copy now and arm yourself with the comprehensive scientific knowledge and evidence-based strategies you need to detect, manage, and prevent drug-resistant infections with authority and confidence.